Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model

  • Authors:
    • Peter Solár
    • Veronika Sačková
    • Gabriela Hrčková
    • Vlasta Demečková
    • Monika Kassayová
    • Bianka Bojková
    • Dagmar Mudroňová
    • Soňa Gancarčíková
    • Rastislav Jendželovský
    • Peter Fedoročko
  • View Affiliations

  • Published online on: November 22, 2016     https://doi.org/10.3892/or.2016.5265
  • Pages: 368-378
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Manumycin A is a natural antibiotic isolated from Streptomyces parvulus with broad range of biological activities including antineoplastic activity in several in vitro and in vivo cancer models. Immodin [dialyzable leukocyte extract (DLE)] is a dialysate released from disintegrated blood leukocytes of healthy donors which exerts immunonormalizing effects on cell-mediated immune responses. The aim of the present study was to explore the antitumor potential of the combination of manumycin A and Immodin in an experimental breast cancer model. Experiments were carried using a 4T1 tumor-bearing BALB/c mouse model. Survival analysis, tumor growth, hematological and biochemical profiles, leukocyte differential, phagocytic activity of leukocytes and histology of the primary tumor were examined. The combination treatment suppressed the tumor growth and prolonged the survival of tumor-bearing mice, decreased the number of monocytes, plateletes and plateletcrit in peripheral blood of the tumor-bearing mice and increased the infiltration of neutrophils and eosinophils in the primary tumor. Moreover, individual therapies enhanced the phagocytic activity of monocytes and neutrophils. These findings demonstrate the antitumor effect of the combination of manumycin A and Immodin in 4T1 tumor-bearing mice associated with strong antiplatelet activity and innate immunity activation.
View Figures
View References

Related Articles

Journal Cover

January-2017
Volume 37 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Solár P, Sačková V, Hrčková G, Demečková V, Kassayová M, Bojková B, Mudroňová D, Gancarčíková S, Jendželovský R, Fedoročko P, Fedoročko P, et al: Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model. Oncol Rep 37: 368-378, 2017
APA
Solár, P., Sačková, V., Hrčková, G., Demečková, V., Kassayová, M., Bojková, B. ... Fedoročko, P. (2017). Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model. Oncology Reports, 37, 368-378. https://doi.org/10.3892/or.2016.5265
MLA
Solár, P., Sačková, V., Hrčková, G., Demečková, V., Kassayová, M., Bojková, B., Mudroňová, D., Gancarčíková, S., Jendželovský, R., Fedoročko, P."Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model". Oncology Reports 37.1 (2017): 368-378.
Chicago
Solár, P., Sačková, V., Hrčková, G., Demečková, V., Kassayová, M., Bojková, B., Mudroňová, D., Gancarčíková, S., Jendželovský, R., Fedoročko, P."Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model". Oncology Reports 37, no. 1 (2017): 368-378. https://doi.org/10.3892/or.2016.5265